ClearPoint Neuro
CLPT
28 hedge funds and large institutions have $7.99M invested in ClearPoint Neuro in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
97% more capital invested
Capital invested by funds: $4.06M → $7.99M (+$3.93M)
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0% more funds holding
Funds holding: 28 → 28 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.76% less ownership
Funds ownership: 7.37% → 6.61% (-0.76%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$87.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$23.8K |
| 4 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$22K |
| 5 |
MFT
Moisand Fitzgerald Tamayo
Orlando,
Florida
|
+$9.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$272K |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$89K |
| 3 |
Millennium Management
New York
|
-$69.5K |
| 4 |
WMC
Westwood Management Corporation
Chicago,
Illinois
|
-$62K |
| 5 |
Renaissance Technologies
New York
|
-$38.2K |
CLPT Hedge Fund Activity: Q3 2020 in Review
28 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2020, worth a combined $7.99M — up 97% from $4.06M a quarter earlier.
Fund positioning in CLPT was balanced in Q3 2020: 3 funds opened new positions, 3 closed out, 7 added to existing stakes and 4 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $87.9K. The largest seller was Worth Venture Partners, exiting entirely with an estimated $272K sold.
- 28 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $7.99M of ClearPoint Neuro stock for Q3 2020, up 97% quarter-over-quarter.
- 3 funds opened new ClearPoint Neuro positions in Q3 2020 and 3 closed out, a net change of 0 holders.
- The largest ClearPoint Neuro buyer in Q3 2020 was Virtu Financial, an estimated $87.9K added.
- The largest ClearPoint Neuro seller in Q3 2020 was Worth Venture Partners, an estimated $272K sold.
Based on aggregated 13F filings for Q3 2020.